INDEMNIFICATION AGREEMENTIndemnification Agreement • December 28th, 2022 • YishengBio Co., LTD • Pharmaceutical preparations
WHEREAS, the Company wishes for the Indemnitee to serve on its Board of Directors (the “Board”) or as an officer of the Company and wishes to provide the Indemnitee with specific contractual assurance of the Indemnitee’s rights to indemnification against litigation risks and expenses arising from his position as a Director or Officer (as defined below) to the full extent permitted by applicable law;
SHARE PURCHASE AGREEMENTShare Purchase Agreement • August 15th, 2024 • LakeShore Biopharma Co., Ltd. • Pharmaceutical preparations • New York
This Share Purchase Agreement (this “Agreement”) is made as of February 7, 2024 by and between YS Biopharma Co., Ltd., an exempted company incorporated in the Cayman Islands (the “Company”) and the purchaser identified on the signature pages hereto (the “Purchaser”). The Company, on one hand, and the Purchaser, on the other hand, are sometimes each referred to herein as a “Party” and collectively as the “Parties.”
IN ACCORDANCE WITH ITEM 601(B)(10)(IV) OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THE EXHIBIT BECAUSE IT IS BOTH (1) NOT MATERIAL AND (2) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [***] INDICATES THAT...Acting-in-Concert Agreement • December 28th, 2022 • YishengBio Co., LTD • Pharmaceutical preparations
SHAREHOLDER SUPPORT AGREEMENT AND DEEDShareholder Support Agreement • September 29th, 2022 • YishengBio Co., LTD • Blank checks • New York
This Shareholder Support Agreement and Deed (this “Agreement”) is made and entered into September 29, 2022, by and among (i) YishengBio Co., Ltd., a Cayman Islands exempted company (the “Company”), (ii) Summit Healthcare Acquisition Corp., a Cayman Islands exempted company (“SPAC”), (iii) Summit Healthcare Acquisition Sponsor LLC, a Cayman Islands limited liability company (“Sponsor”), (iv) certain Persons listed on Schedule A hereto (each, a “YSB Shareholder” and collectively, the “YSB Shareholders”), and (v) certain individuals listed on Schedule B hereto, each of whom is a member of the SPAC Board as of the date hereof (together with Sponsor, the “SPAC Shareholders” and each, a “SPAC Shareholder”). The YSB Shareholders and SPAC Shareholders are hereinafter collectively referred to herein as the “Shareholders” and each individually as a “Shareholder.” Capitalized terms used herein but not defined herein shall have the meaning ascribed to such terms in the Business Combination Agreeme
PLAN OF MERGERPlan of Merger • April 12th, 2023 • YS Biopharma Co., Ltd. • Pharmaceutical preparations
WARRANT ASSIGNMENT AGREEMENT Among Summit HEALTHCARE ACQUISITION CORP., Yishengbio co., ltd. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY Dated September 29, 2022Warrant Assignment Agreement • September 29th, 2022 • YishengBio Co., LTD • Blank checks • New York
This Warrant Assignment Agreement (this “Agreement”), dated September 29, 2022, is made by and among Summit Healthcare Acquisition Corp., a Cayman Islands exempted company (“SPAC”), YishengBio Co., Ltd., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”) and amends the Warrant Agreement (the “Existing Warrant Agreement”), dated June 8, 2021, by and between SPAC and the Warrant Agent. Capitalized terms used but not defined herein shall have the meaning ascribed to such terms in the Existing Warrant Agreement.
EMPLOYMENT AGREEMENTEmployment Agreement • August 15th, 2024 • LakeShore Biopharma Co., Ltd. • Pharmaceutical preparations • New York
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of [DATE] by and between LakeShore Biopharma Co., Ltd. (the “Company”), an exempted company duly incorporated and validly existing under the law of the Cayman Islands, and [NAME], an individual (the “Executive”). The term “Company” as used herein with respect to all obligations of the Executive hereunder shall be deemed to include the Company and all of its direct or indirect parent companies, subsidiaries, affiliates, or subsidiaries or affiliates of its parent companies (collectively, the “Group”).
